Open access · CC-BY via OpenAlex

Geroscience in the Age of COVID-19

Nir Barzilai, James C. Appleby, Steven N. Austad, Ana María Cuervo, Matt R. Kaeberlein, Christian Enrique González-Billault, Stephanie Lederman, Ilia Stambler, Felipe Sierra

Aging and Disease · 2020 · ▲ 42 citations

Epigenetic alterations Human

＋ Sign in to save

Abstract

The data on COVID-19 is clear on at least one point: Older adults are most vulnerable to hospitalization, disability and death following infection with the novel coronavirus. Therefore, therapeutically addressing degenerative aging processes as the main risk factors appears promising for tackling the present crisis and is expected to be relevant when tackling future infections, epidemics and pandemics. Therefore, utilizing a geroscience approach, targeting aging processes to prevent multimorbidity, via initiating broad clinical trials of potential geroprotective therapies, is recommended.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.14336/ad.2020.0629
Canonical: link ↗
Fetched: 2026-10-23 MST

Cite this

APA

Barzilai, N., Appleby, J.C., Austad, S.N., Cuervo, A.M., Kaeberlein, M.R., González-Billault, C.E., Lederman, S., Stambler, I., & Sierra, F. (2020). Geroscience in the Age of COVID-19. <em>Aging and Disease</em>. https://doi.org/10.14336/ad.2020.0629

Vancouver

Barzilai N, Appleby JC, Austad SN, Cuervo AM, Kaeberlein MR, González-Billault CE, et al. Geroscience in the Age of COVID-19. Aging and Disease. 2020. doi:10.14336/ad.2020.0629.

BibTeX

@article{nir2020Gerosc, title = {Geroscience in the Age of COVID-19}, author = {Nir Barzilai and James C. Appleby and Steven N. Austad and Ana María Cuervo and Matt R. Kaeberlein and Christian Enrique González-Billault and Stephanie Lederman and Ilia Stambler and Felipe Sierra}, journal = {Aging and Disease}, year = {2020}, doi = {10.14336/ad.2020.0629}, }